MERITUS CORPORATION – Trademark Portfolio

Entity Type: 03

MERITUS CORPORATION holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 43 (Hotels & Restaurants) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include RELEEV, VIRACEA, PROGINICIN, and SHING-RELEEV. The owner is based in ROSEAU VALLEY.

8 COPTHALL

ROSEAU VALLEY 00152 , DM

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MERITUS CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademarks does MERITUS CORPORATION have?

MERITUS CORPORATION has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 5 cancelled.

What trademark classes does MERITUS CORPORATION file in?

MERITUS CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 43 (Hotels & Restaurants). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MERITUS CORPORATION's most well-known trademarks?

MERITUS CORPORATION's registered trademark portfolio includes well-known marks such as RELEEV, VIRACEA, PROGINICIN, and SHING-RELEEV. These are among 5 currently registered trademarks in the portfolio.

What is MERITUS CORPORATION's trademark registration success rate?

MERITUS CORPORATION has a 42% trademark registration rate, with 5 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.